📰 Use Authorization News
Page 15 - Use Authorization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Use Authorization. Real-time updates on events, politics, business and more.
September 12, 2022
CHMP recommendation based on favorable data from Omicron-adapted vaccines The Omicron BA.4/BA.5 bivalent COVID-19 booster vaccine combines 15-ug of mRNA encoding the wild-type spike protein
September 9, 2022
PRINCETON, N.J., Sept. 9, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions i...
September 7, 2022
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
August 31, 2022
Investegate announcements from BioNTech SE, Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
August 31, 2022
Pfizer and BioNTech plan to aggressively defend against Moderna's claims of patent infringement.
August 23, 2022
Updated analysis from 34 cases occurring at least seven days following a three-dose regimen showed 73.2% vaccine efficacy among children ages 6 months through 4 years The vaccine efficacy
August 23, 2022
Investegate announcements from BioNTech SE, Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
August 16, 2022
/PRNewswire/ -- Maryland Governor Larry Hogan, an outspoken leader throughout the COVID-19 pandemic, toured the headquarters of Maxim Biomedical, an important...
August 9, 2022
The vaccine maker reported dismal Q2 results with a bleaker outlook for the rest of the year.
August 8, 2022
Second quarter revenues of €3.2 billion1, net profit of €1.7 billion and fully diluted earnings per share of €6.45 ($6.872) as well as first half 2022 revenues of €9.6 billion, net profit of €5.4 billion